A detailed history of Howard Financial Services, Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Howard Financial Services, Ltd. holds 2,038 shares of AMGN stock, worth $643,824. This represents 0.1% of its overall portfolio holdings.

Number of Shares
2,038
Previous 2,047 0.44%
Holding current value
$643,824
Previous $589,000 1.7%
% of portfolio
0.1%
Previous 0.11%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$268.87 - $324.56 $2,419 - $2,921
-9 Reduced 0.44%
2,038 $579,000
Q4 2023

Jan 09, 2024

BUY
$255.7 - $288.46 $26,081 - $29,422
102 Added 5.24%
2,047 $589,000
Q3 2023

Oct 10, 2023

SELL
$218.65 - $271.46 $5,903 - $7,329
-27 Reduced 1.37%
1,945 $522,000
Q2 2023

Jul 12, 2023

BUY
$214.27 - $253.37 $42,425 - $50,167
198 Added 11.16%
1,972 $437,000
Q1 2023

Apr 05, 2023

BUY
$225.79 - $275.2 $28,675 - $34,950
127 Added 7.71%
1,774 $428,000
Q4 2022

Jan 13, 2023

BUY
$229.03 - $291.01 $8,932 - $11,349
39 Added 2.43%
1,647 $0
Q3 2022

Oct 12, 2022

BUY
$224.46 - $253.15 $22,446 - $25,315
100 Added 6.63%
1,608 $363,000
Q2 2022

Jul 18, 2022

BUY
$230.71 - $256.74 $6,229 - $6,931
27 Added 1.82%
1,508 $367,000
Q4 2021

Jan 27, 2022

BUY
$198.88 - $227.6 $994 - $1,138
5 Added 0.34%
1,481 $333,000
Q4 2020

Feb 02, 2021

BUY
$216.38 - $257.67 $21,638 - $25,767
100 Added 7.27%
1,476 $339,000
Q3 2020

Nov 12, 2020

BUY
$234.65 - $260.95 $23,465 - $26,095
100 Added 7.84%
1,376 $350,000
Q1 2020

May 05, 2020

BUY
$182.24 - $241.7 $2,004 - $2,658
11 Added 0.87%
1,276 $259,000
Q3 2019

Oct 29, 2019

BUY
$174.11 - $208.62 $16,540 - $19,818
95 Added 8.12%
1,265 $245,000
Q4 2018

Feb 15, 2019

BUY
$178.4 - $208.25 $208,728 - $243,652
1,170 New
1,170 $228,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Howard Financial Services, Ltd. Portfolio

Follow Howard Financial Services, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howard Financial Services, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Howard Financial Services, Ltd. with notifications on news.